ONC Q4 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$214M+113.8% YoY

Gross Profit

$165M77.3% margin

Operating Income

-$572M-267.2% margin

Net Income

-$586M-273.7% margin

EPS (Diluted)

$-6.11

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

-$508M

Free Cash Flow

-$666M

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$2.4B

Stockholders' Equity

$6.1B

Cash & Equivalents

$4.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$214M	$100M	+113.8%
Gross Profit	$165M	$79M	+109.4%
Operating Income	-$572M	-$485M	-17.9%
Net Income	-$586M	-$473M	-23.9%